Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 3 August 2021, 18:00 HKT/SGT
Share:
    

Source: ClinTex (CTi)
ClinTex (CTi) Launches CTi-OEM Blockchain Clinical Trial App

LONDON, Aug 3, 2021 - (ACN Newswire) - The ClinTex (CTi) tokenized platform (clintex.io) will be the first of its kind to utilize blockchain-based clinical data analytics to address the main causes of clinical trial inefficiency, helping to drive down the cost of new medicines and expediting their delivery to patients.

ClinTex (CTi) launches 'Operational Excellence Module' (CTi-OEM) - a blockchain clinical trial application to tackle clinical trial inefficiencies and high costs. (ClinTex)

The initial spark of an idea that would eventually become ClinTex started in 2014, at the DIA Forum in Vienna. By 2018, Clintex was formally working on the Clinical Trials Intelligence (CTi) platform. CTi's purpose is to deliver data analysis at scale, to drive collaboration and insights across clinical trials.

With large pharma companies like Merck and Novartis already testing blockchain as a technology of the future to support their clinical trial strategy for patient information and to manage clinical trial medication, this paves the way for ClinTex CTi to partner with the industry to deliver more innovative and impactful uses of blockchain to increase clinical trial efficiency.

The CTi-OEM App

Leveraging 50+ years of medicine development experience, ClinTex has moved at a breakneck pace to launch its first blockchain clinical trial app of the CTi Platform, the Operational Excellence Module (CTi-OEM). CTi-OEM provides intuitive operational oversight of clinical trials for clinical project managers, clinical data managers and remote staff; allowing in-stream decision-making on what actions are required to ensure a successful investigation into the safety and efficacy of new medicines.

Using the CTi-OEM console, researchers can deep dive into clinical trial data and take proactive action to make clinical trials run more efficiently. These operational issues include things like clinical protocol deviations and adverse events relating to patient safety in the clinical trial.

The company has prioritized the development of the CTi-OEM blockchain clinical trial app to target some of the major causes of inefficiency in clinical trials, enabling its first app to derive maximum tangible benefits for the pharma and clinical trials industry. CTi-OEM achieves this through a comprehensive portfolio of tools, which is accessible through the CTi-OEM console.

Compliance Requirements & Patient Safety

One of the major obstacles to a successful clinical trial is adherence to the clinical trial protocol. Analytics within the CTi-OEM application allows the detection and analysis of these deviations and allows the clinical trial team to take speedy action. These tools provide powerful insights into the major causes of non-compliance in clinical trials providing analytics to help clinical trial teams identify and resolve them to speed up progress.

Protecting patient safety during a clinical trial is the most important aspect in the development of any new medicine. Adverse events are safety issues that occur during the testing of a new medicine. CTi-OEM provides valuable insight into patient safety throughout a clinical trial. For example, adverse event rate per site allows the clinical trial team to identify those sites that have a high rate of safety events which may point to procedural problems or may also uncover safety risks that need further investigation.

These are just a few examples of CTi-OEM's toolkit. For more information on CTi-OEM, there is a series of demonstration videos that give an overview of the platform, and how it can help alleviate pain points in clinical trials. Any clinical trial professionals interested in learning more or becoming early adopters can email ClinTex at industry@clintex.io or visit http://clinicaltrialsintelligence.org.

First Clinical Trials app on the CTi Platform

CTi-OEM is just the beginning for ClinTex offerings. Eventually, the platform will consist of 7 different blockchain clinical trial applications that derive intelligent analytics from all types of clinical trial data, and it is these analytics that can be used to drive efficiency in clinical trials. The ClinTex roadmap is on track to have live client onboarding and revenue generation by the end of 2022.

ClinTex Socials
Twitter : https://twitter.com/ClinTexCTi
Telegram : https://t.me/ClinTexCTi
Medium : https://medium.com/clintexcti
YouTube : https://youtu.be/iK3zkhsDzzA
Website : https://clintex.io/

Contact Details
Email: press@clintex.io

About ClinTex
ClinTex CTi (Clinical Trials Intelligence) is a solution provider to the pharmaceutical industry, a new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use of blockchain technology and smart contracts in clinical trials. Our mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry.


Topic: Press release summary
Source: ClinTex (CTi)

Sectors: Healthcare & Pharm, Blockchain, Clinical Trials
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Toyota Yaris WRC Returns to Home Roads for an Autumn Rally Finland  
Sept 24, 2021 19:30 HKT/SGT
Xilinx and NEC Accelerate Next-Generation 5G Radio Units for Global Deployment   
Sept 24, 2021 18:22 HKT/SGT
Mitsui Chemicals Teams up With NEC and dotData to Trial AI-based Price Change Forecasting for Market-Sensitive Products  
Sept 24, 2021 18:00 HKT/SGT
Moonstake Joins Hyper Protect Accelerator, A Startup Incubator Program of IBM  
Sept 24, 2021 11:00 HKT/SGT
Justin Sun: Preserve the Blockchain Spirit of Compliance and Transparency  
Sept 24, 2021 10:00 HKT/SGT
Fujitsu Sources 100% of Energy Needs for Global HQ from Renewables  
Sept 24, 2021 09:50 HKT/SGT
Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research  
Sept 24, 2021 09:00 HKT/SGT
Honda and Google Collaborate on In-vehicle Connected Services   
Sept 24, 2021 08:16 HKT/SGT
Animoca Brands uses Blockpass' On-chain KYC(TM) to verify NFT prize winners  
Sept 24, 2021 08:00 HKT/SGT
ACROMEC's associate Life Science Incubator launches Co-working Labspace  
Sept 24, 2021 07:00 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: